CN108065352A - 受损细胞的修复口服液制备工艺 - Google Patents
受损细胞的修复口服液制备工艺 Download PDFInfo
- Publication number
- CN108065352A CN108065352A CN201611015940.3A CN201611015940A CN108065352A CN 108065352 A CN108065352 A CN 108065352A CN 201611015940 A CN201611015940 A CN 201611015940A CN 108065352 A CN108065352 A CN 108065352A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- oral liquid
- grams
- preparation process
- honey
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000012907 honey Nutrition 0.000 claims abstract description 18
- 238000000855 fermentation Methods 0.000 claims abstract description 17
- 230000004151 fermentation Effects 0.000 claims abstract description 17
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 16
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 16
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 16
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 16
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 16
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 16
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 16
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 16
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 16
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 16
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 16
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 16
- 230000036541 health Effects 0.000 claims abstract description 16
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 15
- 235000009566 rice Nutrition 0.000 claims abstract description 15
- 235000021419 vinegar Nutrition 0.000 claims abstract description 15
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 13
- 229920002472 Starch Polymers 0.000 claims abstract description 12
- 235000019698 starch Nutrition 0.000 claims abstract description 12
- 239000008107 starch Substances 0.000 claims abstract description 12
- 239000000052 vinegar Substances 0.000 claims abstract description 7
- 239000000654 additive Substances 0.000 claims abstract description 5
- 230000000996 additive effect Effects 0.000 claims abstract description 5
- 238000012856 packing Methods 0.000 claims abstract description 5
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 240000007594 Oryza sativa Species 0.000 claims abstract 5
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract 5
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- 235000010755 mineral Nutrition 0.000 claims description 5
- 235000000346 sugar Nutrition 0.000 claims description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 102000003992 Peroxidases Human genes 0.000 claims description 3
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 claims description 3
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims description 3
- 229960004373 acetylcholine Drugs 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 108010051210 beta-Fructofuranosidase Proteins 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 230000003915 cell function Effects 0.000 claims description 3
- 230000000857 drug effect Effects 0.000 claims description 3
- 235000011073 invertase Nutrition 0.000 claims description 3
- 239000001573 invertase Substances 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 238000005842 biochemical reaction Methods 0.000 claims 1
- 230000001771 impaired effect Effects 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000011084 recovery Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 19
- 241001092040 Crataegus Species 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 241000209094 Oryza Species 0.000 description 10
- 241001247821 Ziziphus Species 0.000 description 10
- 235000013601 eggs Nutrition 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000008439 repair process Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000333181 Osmanthus Species 0.000 description 3
- 235000019082 Osmanthus Nutrition 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001151 other effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000001827 electrotherapy Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了受损细胞的修复口服液制备工艺,它涉及亚健康人体受损细胞的修复技术领域。它的配方包括如下组分:9度米醋350‑500毫升、鸡蛋2‑4个、大枣2‑3个、桂圆干2‑4个、枸杞4‑8粒、山楂2‑4个、葛粉5‑10克、蜂蜜3‑8克;制备工艺流程如下:首先挑选优质米醋和蜂蜜,将鸡蛋去壳、大枣去核,将大枣、桂圆干、枸杞、山楂洗净,然后将准备好的组分混合溶于发酵桶里,进行2‑4天的发酵,纯天然发酵,中途不添加任何其它添加剂,发酵后进行过滤,最后分装打包。本发明有益效果为:它制造成的口服液可用于所有人群的亚健康受损细胞的修复,适用于小孩、成人和老人,适用于酸性体质人群。
Description
技术领域:
本发明涉及亚健康人体受损细胞的修复技术领域,具体涉及受损细胞的修复口服液制备工艺。
背景技术:
亚健康是指人体处于健康和疾病之间的一种状态,处于亚健康状态者,不能达到健康的标准,表现为一定时间内的活力降低、功能和适应能力减退的症状。由于现代人的饮食不合理、缺乏运动、作息不规律、睡眠不足、精神紧张、心理压力大、长期不良情绪等,亚健康人群越来越多。
目前市面上针对亚健康的问题,无非就是采用一些物理疗法或者就医,包括拔罐、刮痧、针灸、牵引、小针刀、电疗、化疗等,短期内治标不治本,反而使得很多人把时间耗进去的同时又得承担身体的痛苦,人们心理上造成了对医院的抗拒。
亚健康问题可以通过修复受损细胞得到解决,从而营造健康身体。细胞修复周期一般如下:1、人体胃细胞7天更新一次;2、皮肤细胞28天左右更新一次;3、肝脏细胞180天更换一次;4、红细胞120天更新一次;5、在一年左右的时间,身体百分之九十八的细胞都会被重新更新一次,而骨细胞更新需要7年时间。人体健康所需的7大元素如下:1、活性钙,增加骨密素;2、活性酵素,生老病死的密码长寿因子;3、胆碱,专门剥离清除血管壁垃圾;4、氨糖,国际公认的骨关节修复素;5、卵磷脂,鸡蛋黄卵磷脂超出大豆卵磷脂的几倍,提高记忆力,防止老年痴呆症;6、小分子肽,具有穿透力,专门通经络,如果经络不通,人吃进去的保健品和钙片得不到吸收,反而会造成二次垃圾毒素堆积;7、低聚糖,是21世纪的功能食品,修复细胞,提高免疫力。
通过多年的数据总结,加上精湛的技术经验,研发出一款目前市面上所没有的创新型的产品,颠覆传统解决亚健康难的难题,它是一款疗效看得见的产品,同时能让人在较短的时间解决亚健康问题,且投入少,具有实际推广价值。
发明内容:
本发明的目的在于针对现有技术的缺陷和不足,提供一种设计合理的受损细胞的修复口服液制备工艺,它制造成的口服液可用于所有人群的亚健康受损细胞的修复,适用于小孩、成人和老人,适用于酸性体质人群。
为了解决背景技术所存在的问题,本发明采用的技术方案为:它的配方包括如下组分:9度米醋350-500毫升、鸡蛋2-4个、大枣2-3个、桂圆干2-4个、枸杞4-8粒、山楂2-4个、葛粉5-10克、蜂蜜3-8克。
制备工艺流程如下:首先挑选优质米醋和蜂蜜,将鸡蛋去壳、大枣去核,将大枣、桂圆干、枸杞、山楂洗净,然后将准备好的350-500毫升9度米醋、2-4个鸡蛋、2-3个大枣、2-4个桂圆干、4-8粒枸杞、2-4个山楂、5-10克葛粉、3-8克蜂蜜混合溶于发酵桶里,进行2-4天的发酵,纯天然发酵,中途不添加任何其它添加剂,发酵后进行过滤,最后分装打包。
发酵合成后的混合溶液含有机酸、氨基酸、原糖、矿物质、维生素、烟酸、泛酸、乙酰胆碱、胡萝卜素、单糖、葡萄糖、多种活性酶;其中矿物质包括钙、铁、锌、钾、磷、硒、钠、镁,维生素包括A、B1、B2、B6、C、D、E、K,多种活性酶包括转化酶、淀粉酶、过氧化酶、磷酸酶、酯酶;酶也就是酵素,中药通过发酵工艺后就产生“酵素”,可以提高药效4到28倍,酶是各种生物化学反应的催化剂,能激活细胞、修复受损细胞、强化细胞功能,使细胞健康繁殖。
本发明有益效果为:它制造成的口服液可用于所有人群的亚健康受损细胞的修复,适用于小孩、成人和老人,适用于酸性体质人群。
具体实施方式:
下面结合具体实施方式,对本发明作进一步的说明。
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合具体实施方式,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施方式仅用以解释本发明,并不用于限定本发明。
具体实施方式一:
本具体实施方式采用如下技术方案:它的配方包括如下组分:9度米醋500毫升、鸡蛋4个、大枣3个、桂圆干4个、枸杞8粒、山楂4个、葛粉10克、蜂蜜8克。
制备工艺流程如下:首先挑选优质米醋和蜂蜜,将鸡蛋去壳、大枣去核,将大枣、桂圆干、枸杞、山楂洗净,然后将准备好的500毫升9度米醋、4个鸡蛋、3个大枣、4个桂圆干、8粒枸杞、4个山楂、10克葛粉、8克蜂蜜混合溶于发酵桶里,进行4天的发酵,纯天然发酵,中途不添加任何其它添加剂,发酵后进行过滤,最后分装打包。
具体实施方式二:
它的配方包括如下组分:9度米醋400毫升、鸡蛋3个、大枣2个、桂圆干3个、枸杞6粒、山楂3个、葛粉8克、蜂蜜6克。
制备工艺流程如下:首先挑选优质米醋和蜂蜜,将鸡蛋去壳、大枣去核,将大枣、桂圆干、枸杞、山楂洗净,然后将准备好的400毫升9度米醋、3个鸡蛋、2个大枣、3个桂圆干、6粒枸杞、3个山楂、8克葛粉、6克蜂蜜混合溶于发酵桶里,进行3天的发酵,纯天然发酵,中途不添加任何其它添加剂,发酵后进行过滤,最后分装打包。
发酵合成后的混合溶液含有机酸、氨基酸、原糖、矿物质、维生素、烟酸、泛酸、乙酰胆碱、胡萝卜素、单糖、葡萄糖、多种活性酶;其中矿物质包括钙、铁、锌、钾、磷、硒、钠、镁,维生素包括A、B1、B2、B6、C、D、E、K,多种活性酶包括转化酶、淀粉酶、过氧化酶、磷酸酶、酯酶;酶也就是酵素,中药通过发酵工艺后就产生“酵素”,可以提高药效4到28倍,酶是各种生物化学反应的催化剂,能激活细胞、修复受损细胞、强化细胞功能,使细胞健康繁殖。
各组分本身的功效详解如下:米醋本身有减肥、抗癌、软化血管、降低胆固醇、降血脂、胃助消化、降血压等功效;鸡蛋有护肤、益智、健脑明目、增强免疫力等功效;大枣有健脾益胃、补气养血、养血安神、缓和药性的功效;桂圆干可健脑安神,桂圆含有多种营养物质,有健脑益智、补养心脾、安神、治失眠、健忘、惊悸等功效,也可抑制子宫肌瘤,桂圆对子宫癌细胞的抑制率超过90%,妇女更年期是妇科肿瘤易发的阶段,适当吃些龙眼有利健康,也可恢复体力,桂圆有补益作用,对病后需要调养及体质虚弱的人有辅助疗效;枸杞有提高机体免疫力的作用,可以补气强精、滋补肝肾、抗衰老、止消渴、暖身体、抗肿瘤、降三高、调节血糖、降低血压,防治高血压、心脏病、动脉硬化等症;山楂有降血脂、防治心血管疾病、降低血压和胆固醇、软化血管及利尿、镇静作用,可开胃消食,特别对消肉食积滞作用更好,很多助消化的药中都采用了山楂,山楂也有活血化淤的功效,有助于解除局部淤血状态,对跌打损伤有辅助疗效;葛粉可解酒,具有清凉下火、开胃下食、利尿解酒等特效,从葛根中提炼出的葛根素具有扩张冠状动脉和脑动脉的作用,可降低血压,能显著增加缺血组织的血液供应量,降低胆固醇和血粘度,抑制血小板聚集,改善微循环,葛粉内含有人体需要的十多种氨基酸和十多种微量元素,其中钙、锌、磷的含量最高,葛粉所含的富硒元素,具有一定的防癌抗癌之功效;蜂蜜是心血管患者的佳品,蜂蜜能改善血液的成分,促进心脑和血管功能,因此经常服用对心血管病人很有好处,蜂蜜对肝脏也有保护作用,能促使肝细胞再生,对脂肪肝的形成有一定的抑制作用,也可增强抵抗力,食用蜂蜜能迅速补充体力、消除疲劳,增强对疾病的抵抗力。
本具体实施方式制造成的口服液可用于所有人群的亚健康受损细胞的修复,适用于小孩、成人和老人,适用于酸性体质人群。
以上所述,仅用以说明本发明的技术方案而非限制,本领域普通技术人员对本发明的技术方案所做的其它修改或者等同替换,只要不脱离本发明技术方案的精神和范围,均应涵盖在本发明的权利要求范围当中。
Claims (3)
1.受损细胞的修复口服液制备工艺,其特征在于配方包括如下组分:9度米醋350-500毫升、鸡蛋2-4个、大枣2-3个、桂圆干2-4个、枸杞4-8粒、山楂2-4个、葛粉5-10克、蜂蜜3-8克。
2.根据权利要求1所述的受损细胞的修复口服液制备工艺,其特征在于制备工艺流程如下:首先挑选优质米醋和蜂蜜,将鸡蛋去壳、大枣去核,将大枣、桂圆干、枸杞、山楂洗净,然后将准备好的350-500毫升9度米醋、2-4个鸡蛋、2-3个大枣、2-4个桂圆干、4-8粒枸杞、2-4个山楂、5-10克葛粉、3-8克蜂蜜混合溶于发酵桶里,进行2-4天的发酵,纯天然发酵,中途不添加任何其它添加剂,发酵后进行过滤,最后分装打包。
3.根据权利要求1所述的受损细胞的修复口服液制备工艺,其特征在于发酵合成后的混合溶液含有机酸、氨基酸、原糖、矿物质、维生素、烟酸、泛酸、乙酰胆碱、胡萝卜素、单糖、葡萄糖、多种活性酶;其中矿物质包括钙、铁、锌、钾、磷、硒、钠、镁,维生素包括A、B1、B2、B6、C、D、E、K,多种活性酶包括转化酶、淀粉酶、过氧化酶、磷酸酶、酯酶;中药通过发酵工艺后就产生“酵素”,提高药效4到28倍,酶是各种生物化学反应的催化剂,能激活细胞、修复受损细胞、强化细胞功能,使细胞健康繁殖。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611015940.3A CN108065352A (zh) | 2016-11-18 | 2016-11-18 | 受损细胞的修复口服液制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611015940.3A CN108065352A (zh) | 2016-11-18 | 2016-11-18 | 受损细胞的修复口服液制备工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108065352A true CN108065352A (zh) | 2018-05-25 |
Family
ID=62160418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611015940.3A Pending CN108065352A (zh) | 2016-11-18 | 2016-11-18 | 受损细胞的修复口服液制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108065352A (zh) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1085399A (zh) * | 1993-09-10 | 1994-04-20 | 十堰市天瑞保健食品开发公司 | 醋蛋生产方法 |
JPH08214834A (ja) * | 1995-02-10 | 1996-08-27 | Tsugumitsu Matsui | 酢卵様混合食品 |
KR20130049289A (ko) * | 2011-11-04 | 2013-05-14 | 전순애 | 홍화 및 초란을 원재료로 한 고칼슘 불고기 양념 제조방법 |
CN103099283A (zh) * | 2012-12-13 | 2013-05-15 | 陈显贵 | 蜂蜜醋蛋液功能保健饮料 |
CN103098886A (zh) * | 2012-12-13 | 2013-05-15 | 陈显贵 | 蜂蜜醋蛋液红枣露功能保健饮料 |
CN105360837A (zh) * | 2015-12-04 | 2016-03-02 | 山东翊弘生物科技有限公司 | 一种醋蛋归元液及其制备方法 |
CN105360836A (zh) * | 2015-12-04 | 2016-03-02 | 山东翊弘生物科技有限公司 | 一种醋蛋液及其制备方法 |
-
2016
- 2016-11-18 CN CN201611015940.3A patent/CN108065352A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1085399A (zh) * | 1993-09-10 | 1994-04-20 | 十堰市天瑞保健食品开发公司 | 醋蛋生产方法 |
JPH08214834A (ja) * | 1995-02-10 | 1996-08-27 | Tsugumitsu Matsui | 酢卵様混合食品 |
KR20130049289A (ko) * | 2011-11-04 | 2013-05-14 | 전순애 | 홍화 및 초란을 원재료로 한 고칼슘 불고기 양념 제조방법 |
CN103099283A (zh) * | 2012-12-13 | 2013-05-15 | 陈显贵 | 蜂蜜醋蛋液功能保健饮料 |
CN103098886A (zh) * | 2012-12-13 | 2013-05-15 | 陈显贵 | 蜂蜜醋蛋液红枣露功能保健饮料 |
CN105360837A (zh) * | 2015-12-04 | 2016-03-02 | 山东翊弘生物科技有限公司 | 一种醋蛋归元液及其制备方法 |
CN105360836A (zh) * | 2015-12-04 | 2016-03-02 | 山东翊弘生物科技有限公司 | 一种醋蛋液及其制备方法 |
Non-Patent Citations (3)
Title |
---|
洪君-健康: ""醋酵素是什么?"神奇"酵素医百病?"", 《360个人图书馆》 * |
王学英等: "醋蛋液的成分及保健功效研究进展 ", 《中国调味品》 * |
范红光FHG: ""醋蛋归元液解说"", 《新浪博客》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103519171A (zh) | 一种仙人掌酵素的制备方法 | |
CN107568736A (zh) | 解酒醒酒医学配方食品 | |
CN103005558A (zh) | 一种健脾开胃饮料及制备方法 | |
CN103005559A (zh) | 一种健脾开胃饮料及其制备方法 | |
CN102813817A (zh) | 一种抗疲劳补肾阳的药酒 | |
CN104855516A (zh) | 一种适宜心脑血管患者调理的醋蛋牛奶饮品的制备方法 | |
CN106173695A (zh) | 一种人心果西番莲蜂蜜饮料及其制作方法 | |
CN103238889A (zh) | 一种抗疲劳苹果醋保健饮料及其制备方法 | |
CN108186883A (zh) | 一种补气养血的中药组合物及其制备方法 | |
CN101675800B (zh) | 一种妇女产后滋补膏及制备方法 | |
CN106135969A (zh) | 一种钙果西番莲蜂蜜饮料及其制作方法 | |
CN109568588A (zh) | 一种益智安神的富硒人参压片糖果及其制备方法 | |
CN101921697A (zh) | 枸杞保健醋 | |
CN108065352A (zh) | 受损细胞的修复口服液制备工艺 | |
CN114010750A (zh) | 一种补肾生血抗衰的参草方 | |
CN102860378A (zh) | 一种降压保健柿子醋茶饮料及其制备方法 | |
CN106474413A (zh) | 一种用于治疗儿童脾胃虚弱、饮食积滞、厌食的口服组合物 | |
CN106261343A (zh) | 一种具有降血压功能的复合保健饮料及其制备方法 | |
CN101756182A (zh) | 泥鳅枣保健胶囊及其制作工艺 | |
CN107362239A (zh) | 一种桂圆药酒 | |
CN107996900A (zh) | 儿童健胃助成长饮料 | |
CN106173703A (zh) | 一种仙人掌西番莲蜂蜜饮料及其制作方法 | |
CN101161124A (zh) | 保健饮料 | |
CN106261283A (zh) | 一种桃金娘西番莲蜂蜜饮料及其制作方法 | |
CN106261278A (zh) | 一种奇异果西番莲蜂蜜饮料及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180525 |
|
WD01 | Invention patent application deemed withdrawn after publication |